Umar Farooq
Hematology & Oncology · State University of Iowa
Credentials: · · · · · · ·
History
Stanford Hospital & Clinics
PinnacleHealth Hospitals
Research
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
New England Journal of Medicine · 2017 · 4,914 citations
The Lancet Oncology · 2019 · 1,921 citations
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
Blood · 2017 · 1,452 citations
25 papers
- GN
24 papers
- BL
20 papers
17 papers
16 papers
- DI
16 papers
16 papers
15 papers · 1 as a fellow
Grants
- 2002–2023
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
National Cancer Institute · P50
Project lead · $244.1K · University of Iowa
Clinical trials
- 2020–2025
CMP-001 for Relapsed and Refractory Lymphoma
Principal investigator · Terminated · Phase 1, Phase 2
Umar Farooq